HEADER BLOOD CLOTTING 09-MAY-02 1LQ8 TITLE CRYSTAL STRUCTURE OF CLEAVED PROTEIN C INHIBITOR CAVEAT 1LQ8 NAG I 1 HAS WRONG CHIRALITY AT ATOM C1 NAG K 1 HAS WRONG CAVEAT 2 1LQ8 CHIRALITY AT ATOM C1 NAG M 1 HAS WRONG CHIRALITY AT ATOM C1 CAVEAT 3 1LQ8 NAG C 10 HAS WRONG CHIRALITY AT ATOM C1 NAG C 357 HAS WRONG CAVEAT 4 1LQ8 CHIRALITY AT ATOM C1 NAG G 359 HAS WRONG CHIRALITY AT ATOM CAVEAT 5 1LQ8 C1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PLASMA SERINE PROTEASE INHIBITOR; COMPND 3 CHAIN: A, C, E, G; COMPND 4 FRAGMENT: N-TERMINAL FRAGMENT FROM ELASTASE CLEAVAGE, RESIDUES 30- COMPND 5 375; COMPND 6 SYNONYM: PCI; PROTEIN C INHIBITOR; PLASMINOGEN ACTIVATOR INHIBITOR-3; COMPND 7 PAI3; ACROSOMAL SERINE PROTEASE INHIBITOR; SERINE/CYSTEINE PROTEINASE COMPND 8 INHIBITOR CLADE A MEMBER 5; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: PLASMA SERINE PROTEASE INHIBITOR; COMPND 11 CHAIN: B, D, F, H; COMPND 12 FRAGMENT: C-TERMINAL FRAGMENT FROM ELASTASE CLEAVAGE, RESIDUES 376- COMPND 13 405; COMPND 14 SYNONYM: PCI; PROTEIN C INHIBITOR; PLASMINOGEN ACTIVATOR INHIBITOR-3; COMPND 15 PAI3; ACROSOMAL SERINE PROTEASE INHIBITOR; SERINE/CYSTEINE PROTEINASE COMPND 16 INHIBITOR CLADE A MEMBER 5 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 ORGAN: LIVER; SOURCE 6 TISSUE: BLOOD; SOURCE 7 OTHER_DETAILS: HUMAN PCI PURIFIED FROM DISCARDED BLOOD PLASMA.; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 ORGAN: LIVER; SOURCE 13 TISSUE: BLOOD; SOURCE 14 OTHER_DETAILS: HUMAN PCI PURIFIED FROM DISCARDED BLOOD PLASMA. KEYWDS SERPIN, PROTEASE, INHIBITOR, HEPARIN, RETINOIC ACID, PROTEIN C, BLOOD KEYWDS 2 CLOTTING EXPDTA X-RAY DIFFRACTION AUTHOR J.A.HUNTINGTON,M.KJELLBERG,J.STENFLO REVDAT 5 16-AUG-23 1LQ8 1 REMARK HETSYN REVDAT 4 29-JUL-20 1LQ8 1 CAVEAT COMPND REMARK HETNAM REVDAT 4 2 1 LINK SITE ATOM REVDAT 3 13-JUL-11 1LQ8 1 VERSN REVDAT 2 24-FEB-09 1LQ8 1 VERSN REVDAT 1 11-FEB-03 1LQ8 0 JRNL AUTH J.A.HUNTINGTON,M.KJELLBERG,J.STENFLO JRNL TITL CRYSTAL STRUCTURE OF PROTEIN C INHIBITOR PROVIDES INSIGHTS JRNL TITL 2 INTO HORMONE BINDING AND HEPARIN ACTIVATION JRNL REF STRUCTURE V. 11 205 2003 JRNL REFN ISSN 0969-2126 JRNL PMID 12575940 JRNL DOI 10.1016/S0969-2126(02)00944-9 REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.66 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 80.6 REMARK 3 NUMBER OF REFLECTIONS : 55034 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOMLY IN THIN SHELLS REMARK 3 R VALUE (WORKING SET) : 0.222 REMARK 3 FREE R VALUE : 0.279 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 2.900 REMARK 3 FREE R VALUE TEST SET COUNT : 1619 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 11359 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 200 REMARK 3 SOLVENT ATOMS : 99 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 53.85 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 27.20000 REMARK 3 B22 (A**2) : -18.95000 REMARK 3 B33 (A**2) : -8.25000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -3.92000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.39 REMARK 3 ESD FROM SIGMAA (A) : 0.57 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.51 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.62 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.500 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : ANISOTROPIC REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: MAXIMUM LIKELIHOOD REMARK 4 REMARK 4 1LQ8 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 20-MAY-02. REMARK 100 THE DEPOSITION ID IS D_1000016178. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-JAN-02 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 19-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0332 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL: SI-111, SI-220 REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : SBC-2 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 55034 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 45.640 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 80.7 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.14800 REMARK 200 R SYM (I) : 0.11200 REMARK 200 FOR THE DATA SET : 19.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.49 REMARK 200 COMPLETENESS FOR SHELL (%) : 27.8 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.48000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.450 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 1EZX REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.70 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.74 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 3350, SODIUM FLUORIDE, REMARK 280 ISOPROPANOL, PH 7, VAPOR DIFFUSION, HANGING DROP AT 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 122.01500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 5380 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16460 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -14.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, I, J REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 5560 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16350 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -13.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D, K REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 4380 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15930 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -31.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 5700 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16490 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -10.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: G, H, L, M REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ARG A 11 REMARK 465 VAL A 12 REMARK 465 GLU A 13 REMARK 465 ASP A 14 REMARK 465 LEU A 15 REMARK 465 HIS A 16 REMARK 465 VAL A 17 REMARK 465 GLY A 18 REMARK 465 ALA A 19 REMARK 465 THR A 20 REMARK 465 VAL A 21 REMARK 465 ALA A 22 REMARK 465 PRO A 23 REMARK 465 SER A 24 REMARK 465 SER A 25 REMARK 465 SER A 355 REMARK 465 ALA A 356 REMARK 465 ARG B 357 REMARK 465 LEU B 358 REMARK 465 ARG C 11 REMARK 465 VAL C 12 REMARK 465 GLU C 13 REMARK 465 ASP C 14 REMARK 465 LEU C 15 REMARK 465 HIS C 16 REMARK 465 VAL C 17 REMARK 465 GLY C 18 REMARK 465 ALA C 19 REMARK 465 THR C 20 REMARK 465 VAL C 21 REMARK 465 ALA C 22 REMARK 465 PRO C 23 REMARK 465 SER C 24 REMARK 465 SER C 25 REMARK 465 ARG C 26 REMARK 465 SER C 355 REMARK 465 ALA C 356 REMARK 465 ARG D 357 REMARK 465 LEU D 358 REMARK 465 ARG E 11 REMARK 465 VAL E 12 REMARK 465 GLU E 13 REMARK 465 ASP E 14 REMARK 465 LEU E 15 REMARK 465 HIS E 16 REMARK 465 VAL E 17 REMARK 465 GLY E 18 REMARK 465 ALA E 19 REMARK 465 THR E 20 REMARK 465 VAL E 21 REMARK 465 ALA E 22 REMARK 465 PRO E 23 REMARK 465 SER E 24 REMARK 465 SER E 25 REMARK 465 SER E 355 REMARK 465 ALA E 356 REMARK 465 ARG F 357 REMARK 465 LEU F 358 REMARK 465 ASN F 359 REMARK 465 ARG G 11 REMARK 465 VAL G 12 REMARK 465 GLU G 13 REMARK 465 ASP G 14 REMARK 465 LEU G 15 REMARK 465 HIS G 16 REMARK 465 VAL G 17 REMARK 465 GLY G 18 REMARK 465 ALA G 19 REMARK 465 THR G 20 REMARK 465 VAL G 21 REMARK 465 ALA G 22 REMARK 465 PRO G 23 REMARK 465 SER G 24 REMARK 465 SER G 25 REMARK 465 ALA G 356 REMARK 465 ARG H 357 REMARK 465 LEU H 358 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 ASN A 79 CG OD1 ND2 REMARK 480 LYS A 82 CB CG CD CE NZ REMARK 480 LYS A 266 CD CE NZ REMARK 480 LYS A 270 CD CE NZ REMARK 480 LYS A 276 CD CE NZ REMARK 480 ARG A 354 CG CD NE CZ NH1 NH2 REMARK 480 LYS C 86 CD CE NZ REMARK 480 LYS C 276 CD CE NZ REMARK 480 HIS C 320 CG ND1 CD2 CE1 NE2 REMARK 480 ARG C 354 CG CD NE CZ NH1 NH2 REMARK 480 ARG E 26 CD NE CZ NH1 NH2 REMARK 480 LYS E 82 CG CD CE NZ REMARK 480 LYS E 86 CD CE NZ REMARK 480 ASP E 104 OD1 OD2 REMARK 480 LYS E 197 CD CE NZ REMARK 480 ARG E 229 CD NE CZ NH1 NH2 REMARK 480 LYS E 266 CE NZ REMARK 480 LYS E 276 CG CD CE NZ REMARK 480 ARG E 354 CG CD NE CZ NH1 NH2 REMARK 480 LYS G 197 CG CD CE NZ REMARK 480 LYS G 270 CD CE NZ REMARK 480 LYS G 273 CE NZ REMARK 480 LYS G 276 CG CD CE NZ REMARK 480 LYS G 297 CE NZ REMARK 480 LYS G 331 CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NE2 GLN G 107 O4 MAN L 2 2.13 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 42 C - N - CA ANGL. DEV. = 9.6 DEGREES REMARK 500 PRO C 42 C - N - CA ANGL. DEV. = 11.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 42 -71.56 -17.40 REMARK 500 SER A 66 -142.27 44.36 REMARK 500 LEU A 80 -5.59 60.80 REMARK 500 GLN A 81 102.30 -171.29 REMARK 500 LYS A 82 -50.00 136.93 REMARK 500 GLU A 85 -60.27 5.65 REMARK 500 PRO A 102 92.00 -48.30 REMARK 500 ARG A 103 -157.42 -62.92 REMARK 500 ASP A 167 75.66 -117.34 REMARK 500 SER A 193 -173.40 -65.67 REMARK 500 ARG A 219 120.68 179.98 REMARK 500 ASP A 221 -173.49 -176.83 REMARK 500 LEU A 226 134.00 -173.60 REMARK 500 SER A 232 69.74 75.72 REMARK 500 ALA A 244 127.45 177.46 REMARK 500 HIS A 320 42.83 -69.30 REMARK 500 SER A 321 167.96 -36.30 REMARK 500 ASN A 322 -71.85 144.51 REMARK 500 ILE A 323 143.58 -16.79 REMARK 500 ASP A 337 -161.63 -124.94 REMARK 500 PRO B 368 146.35 -39.25 REMARK 500 ASP B 375 -129.91 -112.42 REMARK 500 ARG B 386 108.79 -163.43 REMARK 500 PRO C 42 -71.82 -11.28 REMARK 500 SER C 66 -155.26 62.63 REMARK 500 LYS C 82 -31.01 117.53 REMARK 500 PRO C 102 87.11 -13.87 REMARK 500 ARG C 103 -82.71 -67.75 REMARK 500 ASP C 104 -42.56 168.08 REMARK 500 PHE C 106 121.53 -174.05 REMARK 500 GLN C 152 -71.72 -52.18 REMARK 500 VAL C 166 -96.75 -70.72 REMARK 500 ASN C 171 52.43 -154.74 REMARK 500 HIS C 196 -0.54 -55.74 REMARK 500 SER C 232 60.89 69.84 REMARK 500 SER C 264 167.55 175.96 REMARK 500 SER C 318 130.28 171.18 REMARK 500 ASN C 319 -86.89 -71.10 REMARK 500 SER C 321 127.78 133.92 REMARK 500 PHE C 353 -117.17 -96.74 REMARK 500 SER D 360 113.15 69.07 REMARK 500 ASP D 375 -125.72 -134.42 REMARK 500 PRO E 42 -97.77 -28.68 REMARK 500 SER E 66 -139.53 48.06 REMARK 500 LEU E 80 4.39 46.05 REMARK 500 GLN E 81 -50.36 -155.45 REMARK 500 SER E 83 124.02 139.03 REMARK 500 SER E 84 163.20 -31.71 REMARK 500 GLU E 98 34.73 -63.46 REMARK 500 ASN E 100 106.13 -39.46 REMARK 500 REMARK 500 THIS ENTRY HAS 99 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1EZX RELATED DB: PDB REMARK 900 CLEAVED ALPHA-1-ANTITRYPSIN DBREF 1LQ8 A 11 356 UNP P05154 IPSP_HUMAN 30 375 DBREF 1LQ8 C 11 356 UNP P05154 IPSP_HUMAN 30 375 DBREF 1LQ8 E 11 356 UNP P05154 IPSP_HUMAN 30 375 DBREF 1LQ8 G 11 356 UNP P05154 IPSP_HUMAN 30 375 DBREF 1LQ8 B 357 387 UNP P05154 IPSP_HUMAN 376 406 DBREF 1LQ8 D 357 387 UNP P05154 IPSP_HUMAN 376 406 DBREF 1LQ8 F 357 387 UNP P05154 IPSP_HUMAN 376 406 DBREF 1LQ8 H 357 387 UNP P05154 IPSP_HUMAN 376 406 SEQRES 1 A 346 ARG VAL GLU ASP LEU HIS VAL GLY ALA THR VAL ALA PRO SEQRES 2 A 346 SER SER ARG ARG ASP PHE THR PHE ASP LEU TYR ARG ALA SEQRES 3 A 346 LEU ALA SER ALA ALA PRO SER GLN ASN ILE PHE PHE SER SEQRES 4 A 346 PRO VAL SER ILE SER MET SER LEU ALA MET LEU SER LEU SEQRES 5 A 346 GLY ALA GLY SER SER THR LYS MET GLN ILE LEU GLU GLY SEQRES 6 A 346 LEU GLY LEU ASN LEU GLN LYS SER SER GLU LYS GLU LEU SEQRES 7 A 346 HIS ARG GLY PHE GLN GLN LEU LEU GLN GLU LEU ASN GLN SEQRES 8 A 346 PRO ARG ASP GLY PHE GLN LEU SER LEU GLY ASN ALA LEU SEQRES 9 A 346 PHE THR ASP LEU VAL VAL ASP LEU GLN ASP THR PHE VAL SEQRES 10 A 346 SER ALA MET LYS THR LEU TYR LEU ALA ASP THR PHE PRO SEQRES 11 A 346 THR ASN PHE ARG ASP SER ALA GLY ALA MET LYS GLN ILE SEQRES 12 A 346 ASN ASP TYR VAL ALA LYS GLN THR LYS GLY LYS ILE VAL SEQRES 13 A 346 ASP LEU LEU LYS ASN LEU ASP SER ASN ALA VAL VAL ILE SEQRES 14 A 346 MET VAL ASN TYR ILE PHE PHE LYS ALA LYS TRP GLU THR SEQRES 15 A 346 SER PHE ASN HIS LYS GLY THR GLN GLU GLN ASP PHE TYR SEQRES 16 A 346 VAL THR SER GLU THR VAL VAL ARG VAL PRO MET MET SER SEQRES 17 A 346 ARG GLU ASP GLN TYR HIS TYR LEU LEU ASP ARG ASN LEU SEQRES 18 A 346 SER CYS ARG VAL VAL GLY VAL PRO TYR GLN GLY ASN ALA SEQRES 19 A 346 THR ALA LEU PHE ILE LEU PRO SER GLU GLY LYS MET GLN SEQRES 20 A 346 GLN VAL GLU ASN GLY LEU SER GLU LYS THR LEU ARG LYS SEQRES 21 A 346 TRP LEU LYS MET PHE LYS LYS ARG GLN LEU GLU LEU TYR SEQRES 22 A 346 LEU PRO LYS PHE SER ILE GLU GLY SER TYR GLN LEU GLU SEQRES 23 A 346 LYS VAL LEU PRO SER LEU GLY ILE SER ASN VAL PHE THR SEQRES 24 A 346 SER HIS ALA ASP LEU SER GLY ILE SER ASN HIS SER ASN SEQRES 25 A 346 ILE GLN VAL SER GLU MET VAL HIS LYS ALA VAL VAL GLU SEQRES 26 A 346 VAL ASP GLU SER GLY THR ARG ALA ALA ALA ALA THR GLY SEQRES 27 A 346 THR ILE PHE THR PHE ARG SER ALA SEQRES 1 B 31 ARG LEU ASN SER GLN ARG LEU VAL PHE ASN ARG PRO PHE SEQRES 2 B 31 LEU MET PHE ILE VAL ASP ASN ASN ILE LEU PHE LEU GLY SEQRES 3 B 31 LYS VAL ASN ARG PRO SEQRES 1 C 346 ARG VAL GLU ASP LEU HIS VAL GLY ALA THR VAL ALA PRO SEQRES 2 C 346 SER SER ARG ARG ASP PHE THR PHE ASP LEU TYR ARG ALA SEQRES 3 C 346 LEU ALA SER ALA ALA PRO SER GLN ASN ILE PHE PHE SER SEQRES 4 C 346 PRO VAL SER ILE SER MET SER LEU ALA MET LEU SER LEU SEQRES 5 C 346 GLY ALA GLY SER SER THR LYS MET GLN ILE LEU GLU GLY SEQRES 6 C 346 LEU GLY LEU ASN LEU GLN LYS SER SER GLU LYS GLU LEU SEQRES 7 C 346 HIS ARG GLY PHE GLN GLN LEU LEU GLN GLU LEU ASN GLN SEQRES 8 C 346 PRO ARG ASP GLY PHE GLN LEU SER LEU GLY ASN ALA LEU SEQRES 9 C 346 PHE THR ASP LEU VAL VAL ASP LEU GLN ASP THR PHE VAL SEQRES 10 C 346 SER ALA MET LYS THR LEU TYR LEU ALA ASP THR PHE PRO SEQRES 11 C 346 THR ASN PHE ARG ASP SER ALA GLY ALA MET LYS GLN ILE SEQRES 12 C 346 ASN ASP TYR VAL ALA LYS GLN THR LYS GLY LYS ILE VAL SEQRES 13 C 346 ASP LEU LEU LYS ASN LEU ASP SER ASN ALA VAL VAL ILE SEQRES 14 C 346 MET VAL ASN TYR ILE PHE PHE LYS ALA LYS TRP GLU THR SEQRES 15 C 346 SER PHE ASN HIS LYS GLY THR GLN GLU GLN ASP PHE TYR SEQRES 16 C 346 VAL THR SER GLU THR VAL VAL ARG VAL PRO MET MET SER SEQRES 17 C 346 ARG GLU ASP GLN TYR HIS TYR LEU LEU ASP ARG ASN LEU SEQRES 18 C 346 SER CYS ARG VAL VAL GLY VAL PRO TYR GLN GLY ASN ALA SEQRES 19 C 346 THR ALA LEU PHE ILE LEU PRO SER GLU GLY LYS MET GLN SEQRES 20 C 346 GLN VAL GLU ASN GLY LEU SER GLU LYS THR LEU ARG LYS SEQRES 21 C 346 TRP LEU LYS MET PHE LYS LYS ARG GLN LEU GLU LEU TYR SEQRES 22 C 346 LEU PRO LYS PHE SER ILE GLU GLY SER TYR GLN LEU GLU SEQRES 23 C 346 LYS VAL LEU PRO SER LEU GLY ILE SER ASN VAL PHE THR SEQRES 24 C 346 SER HIS ALA ASP LEU SER GLY ILE SER ASN HIS SER ASN SEQRES 25 C 346 ILE GLN VAL SER GLU MET VAL HIS LYS ALA VAL VAL GLU SEQRES 26 C 346 VAL ASP GLU SER GLY THR ARG ALA ALA ALA ALA THR GLY SEQRES 27 C 346 THR ILE PHE THR PHE ARG SER ALA SEQRES 1 D 31 ARG LEU ASN SER GLN ARG LEU VAL PHE ASN ARG PRO PHE SEQRES 2 D 31 LEU MET PHE ILE VAL ASP ASN ASN ILE LEU PHE LEU GLY SEQRES 3 D 31 LYS VAL ASN ARG PRO SEQRES 1 E 346 ARG VAL GLU ASP LEU HIS VAL GLY ALA THR VAL ALA PRO SEQRES 2 E 346 SER SER ARG ARG ASP PHE THR PHE ASP LEU TYR ARG ALA SEQRES 3 E 346 LEU ALA SER ALA ALA PRO SER GLN ASN ILE PHE PHE SER SEQRES 4 E 346 PRO VAL SER ILE SER MET SER LEU ALA MET LEU SER LEU SEQRES 5 E 346 GLY ALA GLY SER SER THR LYS MET GLN ILE LEU GLU GLY SEQRES 6 E 346 LEU GLY LEU ASN LEU GLN LYS SER SER GLU LYS GLU LEU SEQRES 7 E 346 HIS ARG GLY PHE GLN GLN LEU LEU GLN GLU LEU ASN GLN SEQRES 8 E 346 PRO ARG ASP GLY PHE GLN LEU SER LEU GLY ASN ALA LEU SEQRES 9 E 346 PHE THR ASP LEU VAL VAL ASP LEU GLN ASP THR PHE VAL SEQRES 10 E 346 SER ALA MET LYS THR LEU TYR LEU ALA ASP THR PHE PRO SEQRES 11 E 346 THR ASN PHE ARG ASP SER ALA GLY ALA MET LYS GLN ILE SEQRES 12 E 346 ASN ASP TYR VAL ALA LYS GLN THR LYS GLY LYS ILE VAL SEQRES 13 E 346 ASP LEU LEU LYS ASN LEU ASP SER ASN ALA VAL VAL ILE SEQRES 14 E 346 MET VAL ASN TYR ILE PHE PHE LYS ALA LYS TRP GLU THR SEQRES 15 E 346 SER PHE ASN HIS LYS GLY THR GLN GLU GLN ASP PHE TYR SEQRES 16 E 346 VAL THR SER GLU THR VAL VAL ARG VAL PRO MET MET SER SEQRES 17 E 346 ARG GLU ASP GLN TYR HIS TYR LEU LEU ASP ARG ASN LEU SEQRES 18 E 346 SER CYS ARG VAL VAL GLY VAL PRO TYR GLN GLY ASN ALA SEQRES 19 E 346 THR ALA LEU PHE ILE LEU PRO SER GLU GLY LYS MET GLN SEQRES 20 E 346 GLN VAL GLU ASN GLY LEU SER GLU LYS THR LEU ARG LYS SEQRES 21 E 346 TRP LEU LYS MET PHE LYS LYS ARG GLN LEU GLU LEU TYR SEQRES 22 E 346 LEU PRO LYS PHE SER ILE GLU GLY SER TYR GLN LEU GLU SEQRES 23 E 346 LYS VAL LEU PRO SER LEU GLY ILE SER ASN VAL PHE THR SEQRES 24 E 346 SER HIS ALA ASP LEU SER GLY ILE SER ASN HIS SER ASN SEQRES 25 E 346 ILE GLN VAL SER GLU MET VAL HIS LYS ALA VAL VAL GLU SEQRES 26 E 346 VAL ASP GLU SER GLY THR ARG ALA ALA ALA ALA THR GLY SEQRES 27 E 346 THR ILE PHE THR PHE ARG SER ALA SEQRES 1 F 31 ARG LEU ASN SER GLN ARG LEU VAL PHE ASN ARG PRO PHE SEQRES 2 F 31 LEU MET PHE ILE VAL ASP ASN ASN ILE LEU PHE LEU GLY SEQRES 3 F 31 LYS VAL ASN ARG PRO SEQRES 1 G 346 ARG VAL GLU ASP LEU HIS VAL GLY ALA THR VAL ALA PRO SEQRES 2 G 346 SER SER ARG ARG ASP PHE THR PHE ASP LEU TYR ARG ALA SEQRES 3 G 346 LEU ALA SER ALA ALA PRO SER GLN ASN ILE PHE PHE SER SEQRES 4 G 346 PRO VAL SER ILE SER MET SER LEU ALA MET LEU SER LEU SEQRES 5 G 346 GLY ALA GLY SER SER THR LYS MET GLN ILE LEU GLU GLY SEQRES 6 G 346 LEU GLY LEU ASN LEU GLN LYS SER SER GLU LYS GLU LEU SEQRES 7 G 346 HIS ARG GLY PHE GLN GLN LEU LEU GLN GLU LEU ASN GLN SEQRES 8 G 346 PRO ARG ASP GLY PHE GLN LEU SER LEU GLY ASN ALA LEU SEQRES 9 G 346 PHE THR ASP LEU VAL VAL ASP LEU GLN ASP THR PHE VAL SEQRES 10 G 346 SER ALA MET LYS THR LEU TYR LEU ALA ASP THR PHE PRO SEQRES 11 G 346 THR ASN PHE ARG ASP SER ALA GLY ALA MET LYS GLN ILE SEQRES 12 G 346 ASN ASP TYR VAL ALA LYS GLN THR LYS GLY LYS ILE VAL SEQRES 13 G 346 ASP LEU LEU LYS ASN LEU ASP SER ASN ALA VAL VAL ILE SEQRES 14 G 346 MET VAL ASN TYR ILE PHE PHE LYS ALA LYS TRP GLU THR SEQRES 15 G 346 SER PHE ASN HIS LYS GLY THR GLN GLU GLN ASP PHE TYR SEQRES 16 G 346 VAL THR SER GLU THR VAL VAL ARG VAL PRO MET MET SER SEQRES 17 G 346 ARG GLU ASP GLN TYR HIS TYR LEU LEU ASP ARG ASN LEU SEQRES 18 G 346 SER CYS ARG VAL VAL GLY VAL PRO TYR GLN GLY ASN ALA SEQRES 19 G 346 THR ALA LEU PHE ILE LEU PRO SER GLU GLY LYS MET GLN SEQRES 20 G 346 GLN VAL GLU ASN GLY LEU SER GLU LYS THR LEU ARG LYS SEQRES 21 G 346 TRP LEU LYS MET PHE LYS LYS ARG GLN LEU GLU LEU TYR SEQRES 22 G 346 LEU PRO LYS PHE SER ILE GLU GLY SER TYR GLN LEU GLU SEQRES 23 G 346 LYS VAL LEU PRO SER LEU GLY ILE SER ASN VAL PHE THR SEQRES 24 G 346 SER HIS ALA ASP LEU SER GLY ILE SER ASN HIS SER ASN SEQRES 25 G 346 ILE GLN VAL SER GLU MET VAL HIS LYS ALA VAL VAL GLU SEQRES 26 G 346 VAL ASP GLU SER GLY THR ARG ALA ALA ALA ALA THR GLY SEQRES 27 G 346 THR ILE PHE THR PHE ARG SER ALA SEQRES 1 H 31 ARG LEU ASN SER GLN ARG LEU VAL PHE ASN ARG PRO PHE SEQRES 2 H 31 LEU MET PHE ILE VAL ASP ASN ASN ILE LEU PHE LEU GLY SEQRES 3 H 31 LYS VAL ASN ARG PRO MODRES 1LQ8 ASN A 243 ASN GLYCOSYLATION SITE MODRES 1LQ8 ASN A 230 ASN GLYCOSYLATION SITE MODRES 1LQ8 ASN C 230 ASN GLYCOSYLATION SITE MODRES 1LQ8 ASN C 243 ASN GLYCOSYLATION SITE MODRES 1LQ8 ASN C 319 ASN GLYCOSYLATION SITE MODRES 1LQ8 ASN G 230 ASN GLYCOSYLATION SITE MODRES 1LQ8 ASN G 243 ASN GLYCOSYLATION SITE HET NAG I 1 14 HET NDG I 2 14 HET NAG J 1 14 HET NAG J 2 14 HET NAG K 1 14 HET NAG K 2 14 HET MAN L 1 12 HET MAN L 2 11 HET MAN L 3 11 HET NAG M 1 14 HET NDG M 2 14 HET IPA A 901 4 HET NAG C 10 14 HET NAG C 357 14 HET IPA C 902 4 HET NAG G 359 14 HET IPA G 903 4 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM NDG 2-ACETAMIDO-2-DEOXY-ALPHA-D-GLUCOPYRANOSE HETNAM MAN ALPHA-D-MANNOPYRANOSE HETNAM IPA ISOPROPYL ALCOHOL HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN NDG N-ACETYL-ALPHA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY- HETSYN 2 NDG ALPHA-D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2- HETSYN 3 NDG ACETAMIDO-2-DEOXY-GLUCOSE; 2-(ACETYLAMINO)-2-DEOXY-A- HETSYN 4 NDG D-GLUCOPYRANOSE HETSYN MAN ALPHA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN IPA 2-PROPANOL FORMUL 9 NAG 9(C8 H15 N O6) FORMUL 9 NDG 2(C8 H15 N O6) FORMUL 12 MAN 3(C6 H12 O6) FORMUL 14 IPA 3(C3 H8 O) FORMUL 20 HOH *99(H2 O) HELIX 1 1 ASP A 28 ALA A 41 1 14 HELIX 2 2 SER A 49 SER A 61 1 13 HELIX 3 3 LEU A 62 ALA A 64 5 3 HELIX 4 4 GLY A 65 GLY A 77 1 13 HELIX 5 5 GLU A 85 GLU A 98 1 14 HELIX 6 6 GLN A 123 LEU A 133 1 11 HELIX 7 7 ASP A 145 THR A 161 1 17 HELIX 8 8 ASN A 195 THR A 199 5 5 HELIX 9 9 LYS A 255 LEU A 263 1 9 HELIX 10 10 SER A 264 PHE A 275 1 12 HELIX 11 11 LEU A 295 LEU A 299 1 5 HELIX 12 12 PRO A 300 GLY A 303 5 4 HELIX 13 13 SER A 305 THR A 309 5 5 HELIX 14 14 ASP C 28 ALA C 41 1 14 HELIX 15 15 SER C 49 GLY C 63 1 15 HELIX 16 16 GLY C 65 GLY C 75 1 11 HELIX 17 17 SER C 84 GLU C 98 1 15 HELIX 18 18 GLN C 123 LEU C 133 1 11 HELIX 19 19 ASP C 145 THR C 161 1 17 HELIX 20 20 LYS C 255 LEU C 263 1 9 HELIX 21 21 SER C 264 LYS C 273 1 10 HELIX 22 22 LEU C 295 LEU C 299 1 5 HELIX 23 23 PRO C 300 GLY C 303 5 4 HELIX 24 24 SER C 305 THR C 309 5 5 HELIX 25 25 ASP E 28 ALA E 41 1 14 HELIX 26 26 SER E 49 LEU E 62 1 14 HELIX 27 27 GLY E 65 GLY E 77 1 13 HELIX 28 28 GLU E 85 GLU E 98 1 14 HELIX 29 29 GLN E 123 TYR E 134 1 12 HELIX 30 30 ASP E 145 THR E 161 1 17 HELIX 31 31 ASN E 195 THR E 199 5 5 HELIX 32 32 LYS E 255 LEU E 263 1 9 HELIX 33 33 SER E 264 MET E 274 1 11 HELIX 34 34 LEU E 295 LEU E 299 1 5 HELIX 35 35 PRO E 300 GLY E 303 5 4 HELIX 36 36 SER E 305 THR E 309 5 5 HELIX 37 37 ASP G 28 ALA G 41 1 14 HELIX 38 38 SER G 49 GLY G 63 1 15 HELIX 39 39 GLY G 65 LEU G 76 1 12 HELIX 40 40 GLN G 81 GLN G 97 1 17 HELIX 41 41 GLN G 123 TYR G 134 1 12 HELIX 42 42 ASP G 145 THR G 161 1 17 HELIX 43 43 ASN G 195 THR G 199 5 5 HELIX 44 44 LYS G 255 LEU G 263 1 9 HELIX 45 45 SER G 264 PHE G 275 1 12 HELIX 46 46 GLU G 296 GLY G 303 5 8 HELIX 47 47 SER G 305 THR G 309 5 5 SHEET 1 A 6 ILE A 46 PHE A 48 0 SHEET 2 A 6 ILE B 378 VAL B 384 -1 O LEU B 381 N PHE A 48 SHEET 3 A 6 PHE B 369 VAL B 374 -1 N PHE B 369 O VAL B 384 SHEET 4 A 6 THR A 245 PRO A 251 -1 N THR A 245 O VAL B 374 SHEET 5 A 6 CYS A 233 PRO A 239 -1 N ARG A 234 O LEU A 250 SHEET 6 A 6 LEU A 227 ASP A 228 -1 N ASP A 228 O CYS A 233 SHEET 1 B 6 ASP A 137 THR A 141 0 SHEET 2 B 6 PHE A 106 ASP A 117 1 N THR A 116 O THR A 141 SHEET 3 B 6 ALA A 176 LYS A 189 -1 O VAL A 181 N ALA A 113 SHEET 4 B 6 GLY A 340 THR A 352 -1 O ALA A 343 N PHE A 186 SHEET 5 B 6 GLN A 324 VAL A 336 -1 N VAL A 329 O GLY A 348 SHEET 6 B 6 PHE A 287 GLN A 294 -1 N PHE A 287 O VAL A 336 SHEET 1 C 4 GLN A 200 TYR A 205 0 SHEET 2 C 4 VAL A 211 TYR A 225 -1 O VAL A 212 N PHE A 204 SHEET 3 C 4 LYS A 276 PRO A 285 -1 O LEU A 284 N MET A 217 SHEET 4 C 4 GLN B 361 VAL B 364 1 O LEU B 363 N TYR A 283 SHEET 1 D 4 GLN D 361 VAL D 364 0 SHEET 2 D 4 LYS C 276 PRO C 285 1 N GLU C 281 O GLN D 361 SHEET 3 D 4 VAL C 211 ASP C 228 -1 N ASP C 221 O LEU C 280 SHEET 4 D 4 GLN C 200 TYR C 205 -1 N PHE C 204 O VAL C 212 SHEET 1 E 8 GLN D 361 VAL D 364 0 SHEET 2 E 8 LYS C 276 PRO C 285 1 N GLU C 281 O GLN D 361 SHEET 3 E 8 VAL C 211 ASP C 228 -1 N ASP C 221 O LEU C 280 SHEET 4 E 8 CYS C 233 PRO C 239 -1 O CYS C 233 N ASP C 228 SHEET 5 E 8 THR C 245 PRO C 251 -1 O LEU C 250 N ARG C 234 SHEET 6 E 8 PHE D 369 VAL D 374 -1 O VAL D 374 N THR C 245 SHEET 7 E 8 ILE D 378 VAL D 384 -1 O VAL D 384 N PHE D 369 SHEET 8 E 8 ILE C 46 PHE C 48 -1 N ILE C 46 O LYS D 383 SHEET 1 F 6 ASP C 137 THR C 141 0 SHEET 2 F 6 PHE C 106 ASP C 117 1 N THR C 116 O THR C 141 SHEET 3 F 6 ALA C 176 LYS C 189 -1 O LYS C 187 N GLN C 107 SHEET 4 F 6 GLY C 340 THR C 352 -1 O ALA C 343 N PHE C 186 SHEET 5 F 6 GLN C 324 VAL C 336 -1 N GLN C 324 O THR C 352 SHEET 6 F 6 PHE C 287 GLN C 294 -1 N PHE C 287 O VAL C 336 SHEET 1 G 6 ILE E 46 PHE E 48 0 SHEET 2 G 6 ILE F 378 VAL F 384 -1 O LEU F 381 N PHE E 48 SHEET 3 G 6 PHE F 369 VAL F 374 -1 N MET F 371 O GLY F 382 SHEET 4 G 6 THR E 245 PRO E 251 -1 N LEU E 247 O PHE F 372 SHEET 5 G 6 CYS E 233 PRO E 239 -1 N VAL E 238 O ALA E 246 SHEET 6 G 6 LEU E 227 ASP E 228 -1 N ASP E 228 O CYS E 233 SHEET 1 H 6 ASP E 137 THR E 141 0 SHEET 2 H 6 LEU E 110 ASP E 117 1 N LEU E 114 O ASP E 137 SHEET 3 H 6 VAL E 178 LYS E 189 -1 O VAL E 181 N ALA E 113 SHEET 4 H 6 GLY E 340 PHE E 353 -1 O THR E 349 N MET E 180 SHEET 5 H 6 ILE E 323 ASP E 337 -1 N GLN E 324 O THR E 352 SHEET 6 H 6 PHE E 287 GLN E 294 -1 N GLY E 291 O ALA E 332 SHEET 1 I 4 GLN E 200 THR E 207 0 SHEET 2 I 4 THR E 210 GLN E 222 -1 O VAL E 212 N PHE E 204 SHEET 3 I 4 GLN E 279 PRO E 285 -1 O LEU E 280 N ASP E 221 SHEET 4 I 4 GLN F 361 VAL F 364 1 O GLN F 361 N GLU E 281 SHEET 1 J 4 GLN H 361 VAL H 364 0 SHEET 2 J 4 LYS G 276 PRO G 285 1 N GLU G 281 O GLN H 361 SHEET 3 J 4 VAL G 211 ASP G 228 -1 N TYR G 223 O ARG G 278 SHEET 4 J 4 GLN G 200 TYR G 205 -1 N GLN G 200 O MET G 216 SHEET 1 K 8 GLN H 361 VAL H 364 0 SHEET 2 K 8 LYS G 276 PRO G 285 1 N GLU G 281 O GLN H 361 SHEET 3 K 8 VAL G 211 ASP G 228 -1 N TYR G 223 O ARG G 278 SHEET 4 K 8 CYS G 233 PRO G 239 -1 O VAL G 235 N LEU G 226 SHEET 5 K 8 THR G 245 PRO G 251 -1 O LEU G 250 N ARG G 234 SHEET 6 K 8 PHE H 369 VAL H 374 -1 O VAL H 374 N THR G 245 SHEET 7 K 8 ILE H 378 VAL H 384 -1 O VAL H 384 N PHE H 369 SHEET 8 K 8 ILE G 46 PHE G 48 -1 N PHE G 48 O LEU H 381 SHEET 1 L 6 ASP G 137 THR G 141 0 SHEET 2 L 6 PHE G 106 ASP G 117 1 N LEU G 114 O ASP G 137 SHEET 3 L 6 VAL G 178 LYS G 189 -1 O VAL G 181 N ALA G 113 SHEET 4 L 6 GLY G 340 THR G 352 -1 O ALA G 343 N PHE G 186 SHEET 5 L 6 GLN G 324 VAL G 336 -1 N GLU G 327 O ILE G 350 SHEET 6 L 6 PHE G 287 GLN G 294 -1 N PHE G 287 O VAL G 336 LINK ND2 ASN A 230 C1 NAG I 1 1555 1555 1.44 LINK ND2 ASN A 243 C1 NAG J 1 1555 1555 1.44 LINK C1 NAG C 10 ND2 ASN C 319 1555 1555 1.46 LINK ND2 ASN C 230 C1 NAG C 357 1555 1555 1.45 LINK ND2 ASN C 243 C1 NAG K 1 1555 1555 1.46 LINK ND2 ASN G 230 C1 NAG G 359 1555 1555 1.46 LINK ND2 ASN G 243 C1 NAG M 1 1555 1555 1.46 LINK O4 NAG I 1 C1 NDG I 2 1555 1555 1.41 LINK O4 NAG J 1 C1 NAG J 2 1555 1555 1.40 LINK O4 NAG K 1 C1 NAG K 2 1555 1555 1.40 LINK O3 MAN L 1 C1 MAN L 2 1555 1555 1.41 LINK O6 MAN L 1 C1 MAN L 3 1555 1555 1.40 LINK O4 NAG M 1 C1 NDG M 2 1555 1555 1.41 CRYST1 55.200 244.030 66.400 90.00 91.98 90.00 P 1 21 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018116 0.000000 0.000626 0.00000 SCALE2 0.000000 0.004098 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015069 0.00000